Epoch Investment Partners, Inc.Epoch Investment Partners, Inc.

Institutional investor · Portfolio as of Q1 2022

SEC EDGAR SourceSEC Filings

Top Holdings439 positions

Checking export access…
Activity:
Stock
Shares
Value
Weight
Avg Buy
Est. P&L
Held
Conviction

MICROSOFT CORP

2M$624.1M3.1%$137.27+121.69%
13 qtrssince 2019-Q1
Increased
67

APPLE INC

2.3M$396.7M1.9%$124.23+37.47%
13 qtrssince 2019-Q1
Increased
57

BROADCOM INC

578,669$364.4M1.8%$25.39+131.79%
13 qtrssince 2019-Q1
Increased
51

ALPHABET INC-CL C

119,453$333.6M1.6%$71.96+96.75%
13 qtrssince 2019-Q1
Decreased
0
TSMTSM
ADR

TAIWAN SEMICONDUCTOR SPONSORED ADR /1 ADR REPS 5 ORD SHS/

2.6M$272.9M1.3%$65.48+53.01%
13 qtrssince 2019-Q1
Increased
56

T-MOBILE US INC

2M$261.5M1.3%$107.45+15.64%
8 qtrssince 2020-Q2
Decreased
0

NUTRIEN LTD

2.5M$260.7M1.3%$39.34+130.91%
13 qtrssince 2019-Q1
Decreased
0

AMAZON.COM INC

78,762$256.8M1.3%$129.00+28.91%
13 qtrssince 2019-Q1
Increased
50

UNITEDHEALTH GROUP INC

501,459$255.7M1.3%$240.34+103.15%
13 qtrssince 2019-Q1
Increased
52

ABBVIE INC

1.6M$255.4M1.3%$60.33+128.72%
13 qtrssince 2019-Q1
Decreased
0

MERCK & CO. INC.

3M$247.9M1.2%$64.99+13.12%
13 qtrssince 2019-Q1
Increased
54

CISCO SYSTEMS INC

4.4M$247.4M1.2%$44.15+11.22%
13 qtrssince 2019-Q1
Increased
52

VERTEX PHARMACEUTICALS INC

912,697$238.2M1.2%$215.49+19.04%
4 qtrssince 2021-Q2
Increased
54

METLIFE INC

3.4M$237M1.2%$35.88+70.96%
13 qtrssince 2019-Q1
Increased
51

EMERSON ELECTRIC CO

2.3M$228.7M1.1%$69.46+31.42%
13 qtrssince 2019-Q1
Increased
54

INTL BUSINESS MACHINES CORP

1.7M$226.6M1.1%$100.93+9.11%
13 qtrssince 2019-Q1
Increased
50

RAYTHEON TECHNOLOGIES CORP

2.3M$223.9M1.1%$72.15+24.74%
8 qtrssince 2020-Q2
Decreased
0
686,378$219.3M1.1%$165.66+86.87%
13 qtrssince 2019-Q1
Decreased
0

ANALOG DEVICES INC

1.3M$206.7M1.0%$115.27+33.37%
13 qtrssince 2019-Q1
Increased
51

TEXAS INSTRUMENTS INC

1.1M$199.3M1.0%$95.23+69.37%
13 qtrssince 2019-Q1
Increased
45
$20.4B
AUM
439
Positions
Q1 2022
Filing
Rating · 2.5
Quarterly Portfolio Change
+8%Q4'20$21.8B-2%Q1'21$21.4B-13%Q2'21$18.6B-3%Q3'21$18B+9%Q4'21$19.7B+4%Q1'22$20.4B
Activity profile
$ moved · Q1'22
New21%Increased44%Decreased28%Exited7%
Composition
Equity vs derivatives
Equity100%Puts0%Calls0%
Holding period
Avg 1.8 years
<1Q21%1-4Q11%1-2Y13%2Y+55%

Epoch Investment Partners, Inc. manages $20.4B across 439 positions as of Q1 2022. Top holdings: MSFT (3.1%), AAPL (1.9%), AVGO (1.8%). Fund DNA: Steady Compounder. HoldingsIntel Rating: 2.5/5.0.

Q1 2022 Summary

Active quarter - 128 new positions, 33 exits, 212 increased. Top move: MSFT (INCREASED, conviction 67). Portfolio: $20.4B across 439 positions.

Top holdings by portfolio weight

Total AUM$20B
MSFT3.06%
AAPL1.94%
AVGO1.78%
GOOG1.63%
TSM1.34%
TMUS1.28%
NTR1.28%
AMZN1.26%
UNH1.25%
ABBV1.25%
Other1.21%

Portfolio allocation by GICS sector

Sectors11
Technology21.57%
Healthcare16.13%
Financial Services12.25%
Industrials8.85%
Consumer Cyclical8.83%
Communication Services7.08%
Consumer Defensive6.27%
Basic Materials4.95%
Utilities4.78%
Unknown3.36%
Other5.91%

Behavioral investing profile

Checking access…
Steady Compounder- primarily Technology, Healthcare, Financial Services
Compare DNA across all funds
7-dimension quality assessment
Solid(2.5 / 5.0)
Track Record100
Conviction38
Concentration29
Checking access…

Position Outcomes

Best and worst performing positions by estimated return

Cost basis estimates based on full filing history using quarter-end prices. Actual transaction prices are not disclosed in 13F filings.

Similar Funds

Funds with similar investing DNA

Accumulation Streaks

Positions with 2+ consecutive quarters of increases - persistent directional conviction.

Security
5Q
JKHYJKHYJACK HENRY & ASSOCIATES INC
Q2 2025 Q2 2026+534,337 shares+$60.4M
5Q
ACNACNACCENTURE PLC-CL A
Q2 2025 Q2 2026+809,293 shares+$49.1M
4Q
MKCMKCMCCORMICK & CO-NON VTG SHRS
Q3 2025 Q2 2026+661,860 shares+$24.5M
Checking access…

Data sourced from SEC EDGAR 13F filings. Not financial advice. Full disclaimer

Analytics tracking helps us improve the product. Essential functions stay on either way. How analytics data is used